AU2003290797A1 - Compositions and methods utilizing human gamma-hydroxybutyrate receptor - Google Patents

Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Info

Publication number
AU2003290797A1
AU2003290797A1 AU2003290797A AU2003290797A AU2003290797A1 AU 2003290797 A1 AU2003290797 A1 AU 2003290797A1 AU 2003290797 A AU2003290797 A AU 2003290797A AU 2003290797 A AU2003290797 A AU 2003290797A AU 2003290797 A1 AU2003290797 A1 AU 2003290797A1
Authority
AU
Australia
Prior art keywords
compositions
methods utilizing
human gamma
utilizing human
hydroxybutyrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290797A
Other versions
AU2003290797A8 (en
Inventor
Christian Andriamampandry
Jean Paul Humbert
Michel Maitre
Omar Taleb
Eve Van Cauter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SLOWAVE Inc
Original Assignee
SLOWAVE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SLOWAVE Inc filed Critical SLOWAVE Inc
Publication of AU2003290797A8 publication Critical patent/AU2003290797A8/en
Publication of AU2003290797A1 publication Critical patent/AU2003290797A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
AU2003290797A 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor Abandoned AU2003290797A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42619002P 2002-11-14 2002-11-14
US60/426,190 2002-11-14
PCT/US2003/036200 WO2004046315A2 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Publications (2)

Publication Number Publication Date
AU2003290797A8 AU2003290797A8 (en) 2004-06-15
AU2003290797A1 true AU2003290797A1 (en) 2004-06-15

Family

ID=32326319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290797A Abandoned AU2003290797A1 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Country Status (2)

Country Link
AU (1) AU2003290797A1 (en)
WO (1) WO2004046315A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080274A (en) * 1968-08-20 1978-03-21 American Can Company Photopolymerization of lactone-epoxide mixtures with aromatic diazonium salts as photocatalyst
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
WO2004046315A8 (en) 2004-08-26
AU2003290797A8 (en) 2004-06-15
WO2004046315A3 (en) 2004-11-18
WO2004046315A2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003243984A1 (en) Hydrogenated copolymer and composition thereof
AU2003211390A1 (en) Modified hydrogenated copolymer
AU2003220205A1 (en) Ethanol-diesel fuel composition and methods thereof
AU2003237987A1 (en) Novel sweetener compositions and methods of use
AU2003267644A1 (en) Dental compositions and methods
AU2003223096A1 (en) Artificial muscle
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003256805A1 (en) Compounds compositions and methods
AU2003299088A1 (en) Nocturnal muscle enhancing composition and method
AU2002253580A1 (en) Modified block copolymer composition
AU2003252324A1 (en) Fat composition
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003247351A1 (en) Anti-acne compositions and methods of use
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003254677A1 (en) Innervated artificial tissues and uses thereof
AU2003279841A1 (en) Uses of human zven antagonists
AU2003213120A1 (en) Human rnase iii and compositions and uses thereof
AU2003281687A1 (en) Photopolymerizable composition and use thereof
EP1576109A3 (en) Methods and compositions for categorizing patients
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2003282722A1 (en) Therapeutic compositions
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase